Show Notes
What you’ll get out of this episode
Listen in as co-host Rebecca Gwilt chats with Antidote Health CEO Avihai Soudri about the startup scene in Israel, his vision for America's first virtual HMO, and a bit about the shift in VC investment in seed stage companies.
And an extra shout to Antidote Health for closing a $12M seed round of funding last week!
In this episode you’ll discover:
- Why this NY-based company still does so much R&D in Tel Aviv
- What drove Antidote to create an AI-driven virtual HMO
- How Antidote wants to help the large uninsured and underinsured populations in the US
- And a fun final question we don’t want to give away
This lively conversation is one you won’t want to miss if you’re a health system leader, a digital health innovator, a startup founder, or a healthcare tech investor.
Quotables
Recommended Resources
Join the Conversation
Are you a digital health or health system innovator? Tell us what topics and people you’d like us to cover in future episodes:
Follow our daily updates on LinkedIn:
About Your Hosts
Carrie Nixon and Rebecca Gwilt are partners at Nixon Gwilt Law, a healthcare innovation law firm exclusively serving Providers, Digital Health Companies, and Life Science Businesses seeking to transform the way we receive and experience healthcare. Find out more at NixonGwiltLaw.com.
This podcast is produced by Slice of Healthcare LLC.
What is Decoding Healthcare Innovation?
New episodes every other Wednesday. Co-hosted by Carrie Nixon, Esq. & Rebecca E. Gwilt, Esq. Key topics center around healthcare law, policy, innovation, startups & digital health.
Carrie Nixon and Rebecca Gwilt are partners at Nixon Gwilt Law, a healthcare innovation law firm exclusively serving Providers, Digital Health Companies, and Life Science Businesses seeking to transform the way we receive and experience healthcare. Find out more at NixonGwiltLaw.com.